Vice President of Finance Severance AgreementSeverance Agreement • March 23rd, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 23rd, 2017 Company Industry JurisdictionThis Vice President of Finance Severance Agreement (the “Agreement”) is entered into as of July 7, 2015 (the “Effective Date”) by and between Charles N. York II (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
Amended and Restated Patent License Agreement Agreement No. PM1401501Patent License Agreement • March 23rd, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 23rd, 2017 Company Industry JurisdictionThis Amended and Restated Patent License Agreement (“Patent License Agreement”) is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).